Research looks at GIP's role in glycemic control

11/28/2011 |

A study in Diabetes of 10 healthy adult males revealed that glucose-dependent insulinotropic polypeptide infusion boosts glucagon responses during hypoglycemia and euglycemia, without affecting insulin secretion. Experts also found that GIP increases insulin secretion during hyperglycemia by more than twofold, but did not appear to affect glucagon response.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ